10x Genomics (TXG) Other Gross PP&E Adjustments (2018 - 2025)
Historic Other Gross PP&E Adjustments for 10x Genomics (TXG) over the last 8 years, with Q4 2025 value amounting to $295.3 million.
- 10x Genomics' Other Gross PP&E Adjustments rose 129.96% to $295.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $295.3 million, marking a year-over-year increase of 129.96%. This contributed to the annual value of $295.3 million for FY2025, which is 129.96% up from last year.
- Per 10x Genomics' latest filing, its Other Gross PP&E Adjustments stood at $295.3 million for Q4 2025, which was up 129.96% from $314.7 million recorded in Q3 2025.
- In the past 5 years, 10x Genomics' Other Gross PP&E Adjustments registered a high of $323.8 million during Q3 2024, and its lowest value of -$75.7 million during Q1 2022.
- Its 5-year average for Other Gross PP&E Adjustments is $191.7 million, with a median of $292.5 million in 2023.
- As far as peak fluctuations go, 10x Genomics' Other Gross PP&E Adjustments tumbled by 19035.02% in 2022, and later skyrocketed by 53559.88% in 2023.
- 10x Genomics' Other Gross PP&E Adjustments (Quarter) stood at $145.3 million in 2021, then soared by 83.97% to $267.4 million in 2022, then increased by 9.72% to $293.4 million in 2023, then fell by 0.62% to $291.6 million in 2024, then increased by 1.3% to $295.3 million in 2025.
- Its Other Gross PP&E Adjustments stands at $295.3 million for Q4 2025, versus $314.7 million for Q3 2025 and $316.8 million for Q2 2025.